Transfer of Alopecia Areata to C3H/HeJ Mice Using Cultured Lymph Node–Derived Cells  by Wang, Eddy H.C. et al.
Transfer of Alopecia Areata to C3H/HeJ Mice Using
Cultured Lymph Node–Derived Cells
Journal of Investigative Dermatology (2015) 135, 2530–2532; doi:10.1038/jid.2015.176; published online 28 May 2015
TO THE EDITOR
In this study, we present an alopecia
areata (AA) rodent model. The model
avoids the need to perform invasive
surgery by injecting normal haired
mice with cultured skin-draining
lymph node cells (LNCs) derived
from spontaneous AA-affected C3H/
HeJ mice.
AA is a cell-mediated, inﬂammatory,
nonscarring, autoimmune hair loss dis-
ease (Wang and McElwee, 2011). The
exact pathogenesis of AA is still under
investigation, but much of what we do
know about AA is derived from research
using several rodent models (Oliver
et al., 1991; McElwee et al., 1998;
Gilhar et al., 2013).
Spontaneous AA occurs at a low fre-
quency in C3H/HeJ mice; to control
AA onset and increase numbers, a skin-
graft method of transferring AA has been
previously developed (McElwee et al.,
1998). The skin-grafted C3H/HeJ AA
mouse model has been used in basic
research and experimental treatment
investigations (McElwee et al., 2005b;
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Figure 1. The pathologic features of alopecia areata (AA) development resembles other models and human AA with clustering of CD3+ cells around hair
follicles (HFs). (a) The AA-like symptoms in mice that received cultured AA lymph node cells (LNCs) usually initially expanded from one or more patches
on the ventrum, and later the dorsum, of the mice, (b) whereas the mice that received cultured control LNCs remained fully haired even after 20 weeks.
(c) Hematoxylin and eosin (H&E) staining of AA mice showed typical inﬂammatory cell clustering around dystrophic anagen HFs, (d) whereas control
mice had healthy HFs with an absence of inﬂammation. (e) Immunohistochemistry (IHC) analysis showed clustering of CD3+ cells (brown) around HFs
in AA lesions, (f) whereas control mice showed very limited numbers of CD3+ cells in the skin. Scale bar=100 μm (c–f).
Accepted article preview online 6 May 2015; published online 28 May 2015
2530 Journal of Investigative Dermatology (2015), Volume 135 © 2015 The Society for Investigative Dermatology
Sun et al., 2008). However, the need
to perform invasive surgeries on the
mice by a skilled individual, long-term
monitoring for risk of graft rejection
and infection, as well as difﬁculties
in obtaining ethical approval in some
countries, can be drawbacks associated
with this model.
Previously, it was demonstrated that
freshly isolated LNCs from C3H/HeJ AA
mice could be subcutaneously injected
into histocompatible recipients to transfer
the disease (McElwee et al., 2005a).
Potentially, cell injection would be
an easier alternative to skin grafting.
However, large numbers of LNCs are
required, and the number of cells
available from each AA donor is limited
(McElwee et al., 2005a). Therefore, we
investigated whether freshly isolated
AA LNCs could be cultured with stimula-
tory cytokines and then used to induce
AA in normal haired mice. Animal
studies were approved by the University
of British Columbia Animal Care
Committee.
Detailed methodology has been des-
cribed elsewhere (Wang and McElwee,
2014). Brieﬂy, skin-draining lymph
nodes were obtained from AA (either
graft induced or spontaneously deve-
loped) and control, normal haired
C3H/HeJ female donors (The Jackson
Laboratory, Bar Harbor, ME). Single-
LNC suspensions were prepared and
cultured with 30 Uml−1 IL-2 (Roche
Life Science, Laval, QC, Canada),
25 ngml−1 IL-7 (R&D Systems, Minnea-
polis, MN), 50 ngml− 1 IL-15 (R&D
Systems), and Mouse T-Activator CD3/
CD28 Dynabeads (Invitrogen, Burling-
ton, ON, Canada) for 6 days to increase
LNC numbers 8–10-fold. The process
produced enough cells from one donor
to potentially inject 80–100 recipients.
Naive female C3H/HeJ mice at the age
of at least 8 weeks were injected
intradermally with 10 million cells per
mouse (subcutaneous injection was
found to be much less effective in pilot
studies). In some experiments, LNCs
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Figure 2. Colocalization of labeled cells expressing CD4 and CD8 in the skin and inguinal lymph nodes. (a and b) Immunoﬂuorescence labeling revealed
both CD4+ and CD8+ T cells with CM-DiI label in the injected skin at 7 and 11 days for both alopecia areata (AA) and control (Ctrl) mice; no difference
in the intensity was observed. (c and d) No CM-Dil-labeled, CD4+, or CD8+ cells were detected in peripheral skin. (e and f) Inguinal lymph nodes contained
CD4+ and CD8+ cells with CM-DiI label, but no difference was observed between AA and control mice at both time points. (g and h) There were no
labeled cells detected in the spleens of AA and control mice. N= 1 for each group at each time point. Scale bar=25 μm (a, b, e and f) and 50 μm
(c, d, g and h). Images at 11 days are shown.
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were labeled with CM-DiI ﬂuorescent
dye (Invitrogen) before injection.
Within the 20-week observation
period, 90% of mice injected with
cultured AA LNCs developed AA-like
symptoms (Supplementary Figure S1
online). Patchy hair loss consistently
began on the ventral side with dorsal
hair loss developing 2–4 weeks later
(Figure 1a). The control mice stayed fully
haired within the 20-week observation
period (Figure 1b). No difference was
observed in the duration of the latent
period before AA onset with injection of
LNCs into either anagen or telogen skin
(not shown), suggesting that anagen hair
follicles (HFs) are not directly targeted by
injected LNCs. One mouse that received
cultured control LNCs developed AA, but
this was likely a coincidence as C3H/HeJ
mice spontaneously develop AA at a low
rate (Sundberg et al., 1994). Histologi-
cally, skin lesions of cell transfer–induced
AA mice presented with typical clustering
of lymphocytes around dystrophic
anagen hair HFs, similar to skin graft–
induced AA mice and human AA,
whereas control mice exhibited healthy
HFs and the absence of lymphocyte
clustering (Figure 1c and d). Immunohis-
tology showed CD3+ cell accumulation
(Figure 1e and f) and the presence of
CD4+ and CD8+ cells in AA lesions
(Supplementary Figure S2a and d online).
Cultured AA and control LNCs showed
similar changes in surface markers and
intracellular cytokines with activation and
increase in IFNγ-producing T-cells in both
AA and control LNCs (Supplementary
Figure S3a online). Potentially, the cultur-
ing process may promote survival and
enrichment of antigen-speciﬁc T cells or
recently identiﬁed CD8+/NKG2D+ T cells
that have been shown to induce AA (Xing
et al., 2014). Higher levels of regulatory
T cells in the control mice LNCs were
found after culture, but whether this
observation is signiﬁcant in the inability
to induce AA will require further explora-
tion (Supplementary Figure S3b online).
Further investigation into the fate of
injected cells using ﬂow cytometry
showed similar cell localization at 7 and
11 days after injection in both AA and
control mouse skin with comparable
levels of CD3+, CD4+, and CD8+ cells.
Higher percentages of CM-DiI-labeled
LNCs were detected in the skin at
the site of injection (iSkin) compared
with peripheral skin (pSkin) as expected
(Supplementary Figure S4a and b online).
The data are in agreement with immuno-
histology where CM-Dil-labeled CD4+
and CD8+ cells were found in iSkin,
inguinal lymph nodes, and spleens of
both AA and control mice (Figure 2).
At 2 and 4 weeks after injection,
the localization of injected cells was
similar to observations at 7 and 11 days.
No labeled LNCs were observed in AA-
affected lesions in pSkin. Even though
inﬂammatory inﬁltrates were observed
around HFs in AA lesions, it appears that
the injected LNCs did not directly parti-
cipate in the follicular inﬂammation.
Potentially, cultured AA LNCs interact
with the host immune system, inducing
onset of AA mediated by host cells
(Supplementary Figure S5a and b online).
Higher numbers of labeled AA LNCs
were observed in the skin-draining lymph
nodes of AA mice, suggesting greater
migration of activated autoreactive T cells
(Supplementary Figure S5e and f online).
In this study, we developed an AA
mouse model by culture and expansion of
AA mouse–derived LNCs and injection
into normal haired mice. This technique
avoids the need to perform invasive
surgery, use genetic modiﬁcations or
human tissues, and enables the generation
of a large number of AAmice with a single
donor. The success with cultured cell
transfer to induce AA development pro-
vides an alternative to current models and
makes new applications possible. Small,
rare cell populations or even individual
AA LNCs could be expanded to evaluate
their role in AA development. Potentially,
this method of disease induction can also
be applied to other cell-mediated auto-
immune disease animal models.
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